Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study

NCT02853422 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02853422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
January 31, 2017
Enrollment
199 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal neuroendocrine tumours